Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Holt

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Annals of Clinical Biochemistry|June 1, 2002
Monitoring mycophenolic acidDavid W Holt
Current Opinion in Nephrology and Hypertension|October 24, 2002
Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantationDavid W Holt
Transplantation|March 30, 2002
Cyclosporin monitoring based on C2 samplingDavid W Holt
Current Opinion in Nephrology and Hypertension|October 18, 2003
Pharmacogenomics of immunosuppressive drug metabolismSalim Fredericks, David W Holt
Experimental Hematology|May 2, 2006
Comment on: HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 2005; 33(11):1309-1319Salim Fredericks, David W Holt
Therapeutic Drug Monitoring|May 29, 2004
Monitoring immunosuppressive drugs: has it a future?David W Holt, Atholl Johnston
British Journal of Clinical Pharmacology|November 30, 2013
Substandard drugs: a potential crisis for public healthAtholl Johnston, David W Holt
European Heart Journal|June 23, 2006
Pregnancy-associated plasma protein-A and cardiovascular riskJuan Carlos Kaski, David W Holt
The Journal of Extra-Corporeal Technology|January 6, 2018
Colloid Oncotic Pressure, Monitoring its Effects in Cardiac SurgeryJeffrey B Chores, David W Holt
The Journal of Extra-Corporeal Technology|May 3, 2016
Removal of Gross Air Embolization from Cardiopulmonary Bypass Circuits with Integrated Arterial Line Filters: A Comparison of Circuit DesignsJames A Reagor, David W Holt
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Annals of Clinical Biochemistry|June 1, 2002
Monitoring mycophenolic acidDavid W Holt
Current Opinion in Nephrology and Hypertension|October 24, 2002
Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantationDavid W Holt
Transplantation|March 30, 2002
Cyclosporin monitoring based on C2 samplingDavid W Holt
Current Opinion in Nephrology and Hypertension|October 18, 2003
Pharmacogenomics of immunosuppressive drug metabolismSalim Fredericks, David W Holt
Experimental Hematology|May 2, 2006
Comment on: HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 2005; 33(11):1309-1319Salim Fredericks, David W Holt
Therapeutic Drug Monitoring|May 29, 2004
Monitoring immunosuppressive drugs: has it a future?David W Holt, Atholl Johnston
British Journal of Clinical Pharmacology|November 30, 2013
Substandard drugs: a potential crisis for public healthAtholl Johnston, David W Holt
European Heart Journal|June 23, 2006
Pregnancy-associated plasma protein-A and cardiovascular riskJuan Carlos Kaski, David W Holt
The Journal of Extra-Corporeal Technology|January 6, 2018
Colloid Oncotic Pressure, Monitoring its Effects in Cardiac SurgeryJeffrey B Chores, David W Holt
The Journal of Extra-Corporeal Technology|May 3, 2016
Removal of Gross Air Embolization from Cardiopulmonary Bypass Circuits with Integrated Arterial Line Filters: A Comparison of Circuit DesignsJames A Reagor, David W Holt
Pageof 11